Targeting metabolism to enhance immunotherapy within tumor microenvironment

X Liang, X Chen, Y Yan, A Cheng, J Lin… - Acta Pharmacologica …, 2024 - nature.com
Cancer metabolic reprogramming has been considered an emerging hallmark in
tumorigenesis and the antitumor immune response. Like cancer cells, immune cells within …

Nucleoside‐based drug target with general antimicrobial screening and specific computational studies against SARS‐CoV‐2 main protease

SMA Kawsar, MA Hossain, S Saha… - …, 2024 - Wiley Online Library
This review article aims to significantly advance the scientific community's efforts to develop
effective nucleoside‐based drugs for treating severe acute respiratory syndrome …

Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance

T Scolaro, M Manco, M Pecqueux, R Amorim, R Trotta… - Nature Cancer, 2024 - nature.com
Many individuals with cancer are resistant to immunotherapies. Here, we identify the gene
encoding the pyrimidine salvage pathway enzyme cytidine deaminase (CDA) among the top …

Salvage of ribose from uridine or RNA supports glycolysis in nutrient-limited conditions

OS Skinner, J Blanco-Fernández, RP Goodman… - Nature …, 2023 - nature.com
Glucose is vital for life, serving as both a source of energy and carbon building block for
growth. When glucose is limiting, alternative nutrients must be harnessed. To identify …

UPP1 promotes lung adenocarcinoma progression through the induction of an immunosuppressive microenvironment

Y Li, M Jiang, L Aye, L Luo, Y Zhang, F Xu… - Nature …, 2024 - nature.com
The complexity of the tumor microenvironment (TME) is a crucial factor in lung
adenocarcinoma (LUAD) progression. To gain deeper insights into molecular mechanisms …

Transketolase promotes MAFLD by limiting inosine-induced mitochondrial activity

L Tong, Z Chen, Y Li, X Wang, C Yang, Y Li, Y Zhu… - Cell Metabolism, 2024 - cell.com
Metabolic dysfunction-associated fatty liver disease (MAFLD) has a global prevalence of
about 25% and no approved therapy. Using metabolomic and proteomic analyses, we …

UPP1 enhances bladder cancer progression and gemcitabine resistance through AKT

W Du, S Tu, W Zhang, Y Zhang, W Liu… - … journal of biological …, 2024 - pmc.ncbi.nlm.nih.gov
UPP1, a crucial pyrimidine metabolism-related enzyme, catalyzes the reversible
phosphorylation of uridine to uracil and ribose-1-phosphate. However, the effects of UPP1 in …

Nucleosides are overlooked fuels in central carbon metabolism

A Strefeler, J Blanco-Fernandez, AA Jourdain - Trends in Endocrinology & …, 2024 - cell.com
From our daily nutrition and synthesis within cells, nucleosides enter the bloodstream and
circulate throughout the body and tissues. Nucleosides and nucleotides are classically …

Crosstalk between metabolic remodeling and epigenetic reprogramming: A new perspective on pancreatic cancer

J Ren, B Ren, X Liu, M Cui, Y Fang, X Wang, F Zhou… - Cancer letters, 2024 - Elsevier
Pancreatic cancer is a highly malignant solid tumor with a poor prognosis and a high
mortality rate. Thus, exploring the mechanisms underlying the development and progression …

Uridine and its role in metabolic diseases, tumors, and neurodegenerative diseases

Y Yang, Y Ye, Y Deng, L Gao - Frontiers in Physiology, 2024 - frontiersin.org
Uridine is a pyrimidine nucleoside found in plasma and cerebrospinal fluid with a
concentration higher than the other nucleosides. As a simple metabolite, uridine plays a …